IMMURON LIMITED (IMRN) Financial Statements
IMMURON LIMITED (IMRN) files with the U.S. Securities and Exchange Commission under CIK 0001660046. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2026
- Revenue
- 7.71 million AUD
- Net Income
- -3.68 million AUD
- Total Assets
- 13.15 million AUD
- Net Cash from Operations
- -3.26 million AUD
Fiscal year ended Jun 30, 2026. Latest periodic SEC filing: Sep 24, 2026. Source: SEC filings (EDGAR XBRL). Amounts in AUD.
Open the full financial statements for IMRN in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History